Steven Ryder - 11 Jul 2022 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role
Director
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Jul 2022
Net transactions value
+$316,852
Form type
4
Filing time
12 Jul 2022, 16:26:23 UTC
Previous filing
09 Feb 2022
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Award $29,545 +913 $32.36 913 11 Jul 2022 Direct F1, F2
transaction RETA Class A common stock Award $134,974 +4,171 +457% $32.36 5,084 11 Jul 2022 Direct F3
transaction RETA Class A common stock Award $122,774 +3,794 +75% $32.36 8,878 11 Jul 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right-to-buy) Award $29,560 +1,322 $22.36 1,322 11 Jul 2022 Class A common stock 1,322 $32.36 Direct F5, F6
transaction RETA Stock Option (right-to-buy) Award $0 +6,038 $0.000000 6,038 11 Jul 2022 Class A common stock 6,038 $32.36 Direct F7
transaction RETA Stock Option (right-to-buy) Award $0 +5,492 $0.000000 5,492 11 Jul 2022 Class A common stock 5,492 $32.36 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent Restricted Stock Units (RSU), which vest on June 7, 2023, subject to continued service through the vesting date.
F2 These RSU were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $29,545.00.
F3 These shares represent RSU that vest in three equal yearly installments, subject to continued service through each vesting date.
F4 These shares represent RSU that vest on June 7, 2023, subject to continued service through the vesting date.
F5 The options vest in four equal installments on September 8, 2022, December 8, 2022, March 8, 2023, and June 7, 2023, subject to continued service through each vesting date.
F6 These options were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $29,557.00.
F7 The options vest in three equal yearly installments, subject to continued service through each vesting date.